← All trials
NCT04513171
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 26, 2018
- Primary completion
- Nov 20, 2022
- Completion date
- Dec 31, 2022
- First posted
- Aug 14, 2020
- Last posted
- Nov 6, 2020
- Enrollment
- 400
- Arms / groups
- 6 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Xiamen Amoytop Biotech Co., Ltd.Lead sponsor
- Huazhong University of Science and TechnologyCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.